Recombinant lubricin molecules and uses thereof

Details Recombinant lubricin molecules and uses thereof Recombinant lubricin molecules and uses thereof

2011-03-01

2011-03-01

Carlson, Karen Cochrane (Department: 1652)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S350000, C435S069100

Reexamination Certificate

active

07897571

ABSTRACT:
Recombinant lubricin molecules and uses thereof. Novel recombinant lubricin molecules and their uses as lubricants, anti-adhesive agents and/or intra-articular supplements for, e.g., synovial joints, meniscus, tendon, peritoneum, pericardium and pleura, are provided.

REFERENCES:
patent: 2487377 (1949-11-01), Roehner et al.
patent: 2734862 (1956-02-01), Morway et al.
patent: 2878184 (1959-03-01), March
patent: 4108849 (1978-08-01), Thomas
patent: 4438100 (1984-03-01), Balslev et al.
patent: 5260417 (1993-11-01), Grant et al.
patent: 5326558 (1994-07-01), Turner et al.
patent: 5403592 (1995-04-01), Hills
patent: 5510121 (1996-04-01), Rhee et al.
patent: 5510122 (1996-04-01), Sreebny et al.
patent: 5515590 (1996-05-01), Pienkowski
patent: 5605938 (1997-02-01), Roufa et al.
patent: 5612028 (1997-03-01), Sackier et al.
patent: 5639796 (1997-06-01), Lee
patent: 5702456 (1997-12-01), Pienkowski
patent: 5709020 (1998-01-01), Pienkowski et al.
patent: 6433142 (2002-08-01), Turner et al.
patent: 6743774 (2004-06-01), Jay
patent: 6960562 (2005-11-01), Jay
patent: 7001881 (2006-02-01), Jay
patent: 2004/0229804 (2004-11-01), Jay
patent: 781564 (2001-01-01), None
patent: 2367750 (2000-11-01), None
patent: 1440981 (2004-07-01), None
patent: WO 92/13075 (1992-08-01), None
patent: WO 95/23861 (1995-09-01), None
patent: WO 00/64930 (2000-11-01), None
patent: WO 01/07068 (2001-02-01), None
patent: WO 02/062847 (2002-08-01), None
Results 1 and 2, database search of sequences in issued U.S. patents, alignments of instant SEQ ID No. 7 with SEQ ID Nos. 2 and 62 of Turner et al., US 6,433,142, searched on Feb. 19, 2010.
Aydelotte et al., “Heterogeneity of Articular Chondrocytes,” Articular Cartilage and Osteoarthritis, Raven Press Ltd., New York, pp. 237-249 (1992).
Caron, J.P., “Understanding the Pathogenesis of Equine Osteoarthritis,”Br. Vet. J. Sci., USA149:369-371 (1992).
Chambers et al., “Matrix Metalloproteinases and Aggrecanases Cleave Aggrecan in Different Zones of Normal Cartilage but Colocalize in the Development of Osteoarthritic Lesions in STR/ort Mice,”Arthritis&Rheumatism, 44(6):1455-1465 (2001).
Davis et al., “A proposed model of boundary lubrication by synovial fluid: structuring of boundary water,”Journal of Biomechanical Engineering, 101:185-192 (Aug. 1979).
Espallargues and Pons, “Efficacy and Safety of Viscosupplementation with Hylan G-F 20 for the Treatment of Knee Osteoarthritis: A Systematic Review,”International Journal of Technology Assessment in Helath Care, 19(1):41-56 (2003).
European Search Report dated Jul. 6, 2009 for related European Appl. No. 04781229.2.
Flannery et al., “Articular Cartilage Superficial Zone Protein (SZP) is Homologous to Megakaryocyte Stimulating Factor Precursor and is a Multifunctional Proteoglycan with Potential Growth-Promoting, Cytoprotective, and Lubricating Properties in Cartilage Metabolism,”Biochemical and Biophysical Research Communications, 254:535-541 (1999).
Garg et al., “The Structure of the O-Glycosylically-linked Oligosacharide Chains of LPG-I, A Glycoprotein Present in Articular Lubricating Fraction of Bovine Synovial Fluid,”Carbohydrate Research, 78:79-88 (1979).
Glasson et al., “Characterization of and Osteoarthritis Susceptibility in ADAMTS-4-Knockout Mice,”Arthritis&Rheumatism, 50(8):2547-2558 (2004).
Goldberg et al., “Prevention of Postoperative Adhesions by Precoating Tissues with Dilute Sodium Hyaluronate Solutions,” In:Gynecologic Surgery and Adhesion Prevention, (Willey-Liss), pp. 191-204 (1993).
Hills et al., “Deficiency of lubricating surfactant lining the articular surfaces of replaced hips and knees,”British Journal of Rheumatology, 37:143-147 (1998).
Hills et al., “Ezymatic identification of the load-bearing boundary lubricant in the joint,” BritishJournal of Rheumatology, 37:137-142 (1998).
Hills, Brian A., “Identity of the Joint Lubricant,”The Journal of Rheumatology, 29:200-201 (2002).
Ikegawa et al., “Isolation, characterization and mapping of the mouse and human PRG4 (proteoglycan 4) genes,”Cytogenet. Cell Genet., 90:291-297 (2000).
Jay et al, “Homology of lubricin and superficial zone protein (SZP): products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25,”J. Orthop. Res., 19:677-687, (2001).
Jay et al., “Boundary lubrication by lubricin is mediated by O-linked β(1-3)Gal-GalNAc oligosaccharides,”Glycoconjugate Journal, 18:807-815 (2001).
Jay et al., “Comparison of the boundary-lubricating ability of bovine synovial fluid, lubricin, and Healon,”Biomed. Mater. Res., 40:414-418 (1998).
Jay et al., “Lubricin is a product of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts,”American College of Rheumatology, vol. 42, No. 9 (Supplement) (Sep. 1999).
Jay et al., “Silver Staining of Extensively Glycosylated Proteins on Sodium Dodecyl Sulfate-Polyacrylamide Gels: Enhancement by Carbohydrate-Binding Dyes,”Analytical Biochemistry, 185:324-330 (1990).
Jay, “Characterization of a Bovine Synovial Fluid Lubricating Factor. I. Chemical, Surface Activity and Lubricating Properties,”Connective Tissue Research, 28:71-88 (1992).
Jay et al., “Characterization of a Bovine Synovial Fluid Lubricating Factor. II. Comparison with Purified Ocular and Salivary Mucin,”Connective Tissue Research, 28:89-98 (1992).
Jay et al., “Characterization of a Bovine Synovial Fluid Lubricating Factor. III. The Interaction with Hyaluronic Acid,”Connective Tissue Research, 28:245-255 (1992).
Jay, Gregory D., “Joint lubrication: A physicochemical study of a purified lubricating factor from bovine synovial fluid,” State University of New York at Stony Brook (1990).
Jay, Gregory, “Lubricin and surfacing of articular joints,”Curr. Opin. Orthop., 15:355-359 (2004).
Krstenansky and Mao, “Antithrombin properties of C-terminus of hirudin using synthetic unsulfated Nα-acetyl-hirudin45-65,”FEBS Letter, 211(1):10-16 (1987).
Lorenzo et al., “A Novel Cartilage Protein (CILP) Present in the Mid-zone of Human Articular Cartilage Increases with Age,”J. of Biol. Chem.273(36):23463-23468 (1998).
Lorenzo et al., “Cloning and Deduced Amino Acid Sequence of a Novel Cartilage protein (CLIP) Identifies a Profrom Including a Nucleotide Pyrophosphohydrolase,”J. Biol. Chem., 273(36):23469-23475 (1998).
Marcelino et al., “CACP, encoding a secreted proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome,”Nature Genetics, 23:319-322 (1999).
Marcelino et al., “Mutations in a secreted proteoglycan cause a human disease characterized by synovial and pericardial cell hyperplasia,” Abstracts Presented at the 39thAmerican Society for Cell Biology Annual Meeting , Washington, DC (Dec. 11-15, 1999).
Marcelino et al., “The gene for the camptodactyly-arthropathy-coxa vara-pericarditis syndrome (CACP) encodes a secreted proteoglycan that is essential to normal joint function,”The American Journal of Human Genetics, vol. 65, No. 4 (Oct. 1999), Abstract only.
Merberg et al., “A Comparison of Vitronectin and Megakaryocyte Stimulating Factor,”Biology of Vitronectins and their Receptors, Preissner et al., Editors, Elsevier Science, Amsterdam, pp. 45-53 (1993).
Merrifield, R. B., “Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide,”J. Amer. Chem. Soc., 85:2149-2154 (1963).
Morawietz et al., “Differential gene expression in the periprosthetic membrane: lubricin as a new possible pathogenetic factor in prosthesis loosening,”Virchows Arch, 443:57-66 (2003).
Rees et al., “Immunolocalisation and expression of proteoglycan 4 (cartilage superficial zone proteoglycan) i

Affiliated with

Also associated with

Rating

Recombinant lubricin molecules and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Recombinant lubricin molecules and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant lubricin molecules and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2626889